Rosuvastatin

Modify Date: 2025-08-21 12:33:01

Rosuvastatin Structure
Rosuvastatin structure
 Common Name Rosuvastatin
CAS Number 287714-41-4 Molecular Weight 481.54
Density 1.368 g/cm3 Boiling Point 745.6ºC at 760 mmHg
Molecular Formula C22H28FN3O6S Melting Point N/A
MSDS N/A Flash Point 404.7ºC

 Use of Rosuvastatin


Rosuvastatin is a competitive inhibitor of HMG-CoA reductase with IC50 of 11 nM. IC50 Value: 11 nM [1]Target: HMG-CoA reductasein vitro: Rosuvastatin is relatively hydrophilic and is highly selective for hepatic cells; its uptake is mediated by the liver-specific organic anion transporter OATP-C. Rosuvastatin is a high-affinity substrate for OATP-C with apparent association constant of 8.5 μM [2]. Rosuvastatin inhibits cholesterol biosynthesis in rat liver isolated hepatocytes with IC50 of 1.12 nM. Rosuvastatin causes approximately 10 times greater increase of mRNA of LDL receptors than pravastatin [1]. Rosuvastatin (100 μM) decreases the extent of U937 adhesion to TNF-α-stimulated HUVEC. Rosuvastatin inhibits the expressions of ICAM-1, MCP-1, IL-8, IL-6, and COX-2 mRNA and protein levels through inhibition of c-Jun N-terminal kinase and nuclear factor-kB in endothelial cells [3].in vivo: Rosuvastatin (3 mg/kg) daily administration for 14 days decreases plasma cholesterol levels by 26% in male beagle dogs with normal cholesterol levels. In cynomolgus monkeys, Rosuvastatin decreases plasma cholesterol levels by 22% [1]. Rosuvastatin (20 mg/kg/day) administration for 2 weeks, significantly reduces very low-density lipoproteins (VLDL) in diabetes mellitus rats induced by Streptozocin [4]. Rosuvastatin shows antiatherothromhotic effects in vivo. Rosuvastatin (1.25 mg/kg) significantly inhibits thrombin-induced transmigration of monocvtes across mesenteric venules via inhibition of the endothelial cell surface expression of P-selectin, and increases the basal rate of nitric oxide in aortic segments by 2-fold times [5].

 Names

Name rosuvastatin
Synonym More Synonyms

 Rosuvastatin Biological Activity

Description Rosuvastatin is a competitive inhibitor of HMG-CoA reductase with IC50 of 11 nM. IC50 Value: 11 nM [1]Target: HMG-CoA reductasein vitro: Rosuvastatin is relatively hydrophilic and is highly selective for hepatic cells; its uptake is mediated by the liver-specific organic anion transporter OATP-C. Rosuvastatin is a high-affinity substrate for OATP-C with apparent association constant of 8.5 μM [2]. Rosuvastatin inhibits cholesterol biosynthesis in rat liver isolated hepatocytes with IC50 of 1.12 nM. Rosuvastatin causes approximately 10 times greater increase of mRNA of LDL receptors than pravastatin [1]. Rosuvastatin (100 μM) decreases the extent of U937 adhesion to TNF-α-stimulated HUVEC. Rosuvastatin inhibits the expressions of ICAM-1, MCP-1, IL-8, IL-6, and COX-2 mRNA and protein levels through inhibition of c-Jun N-terminal kinase and nuclear factor-kB in endothelial cells [3].in vivo: Rosuvastatin (3 mg/kg) daily administration for 14 days decreases plasma cholesterol levels by 26% in male beagle dogs with normal cholesterol levels. In cynomolgus monkeys, Rosuvastatin decreases plasma cholesterol levels by 22% [1]. Rosuvastatin (20 mg/kg/day) administration for 2 weeks, significantly reduces very low-density lipoproteins (VLDL) in diabetes mellitus rats induced by Streptozocin [4]. Rosuvastatin shows antiatherothromhotic effects in vivo. Rosuvastatin (1.25 mg/kg) significantly inhibits thrombin-induced transmigration of monocvtes across mesenteric venules via inhibition of the endothelial cell surface expression of P-selectin, and increases the basal rate of nitric oxide in aortic segments by 2-fold times [5].
Related Catalog
References

[1]. Watanabe, M., et al., Synthesis and biological activity of methanesulfonamide pyrimidine- and N-methanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates, a novel series of HMG-CoA reductase inhibitors. Bioorg Med Chem, 1997. 5(2): p. 437-44.

[2]. Schneck, D.W., et al., The effect of gemfibrozil on the pharmacokinetics of rosuvastatin. Clin Pharmacol Ther, 2004. 75(5): p. 455-63.

[3]. Kim, Y.S., et al., Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells. J Cardiovasc Pharmacol, 2007. 49(6): p. 376-83.

[4]. Carswell, C.I., G.L. Plosker, and B. Jarvis, Rosuvastatin. Drugs, 2002. 62(14): p. 2075-85; discussion 2086-7.

[5]. Stalker, T.J., A.M. Lefer, and R. Scalia, A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. Br J Pharmacol, 2001. 133(3): p. 406-12.

 Chemical & Physical Properties

Density 1.368 g/cm3
Boiling Point 745.6ºC at 760 mmHg
Molecular Formula C22H28FN3O6S
Molecular Weight 481.54
Flash Point 404.7ºC
PSA 152.13000
LogP 2.14780
Vapour Pressure 2.38E-23mmHg at 25°C
Index of Refraction 1.597
Storage condition 2-8°C

 Synthetic Route

 Synonyms

Reference source: Negwer
volume-3 compound no
ROSUVASTATIN-D3 SODIUM SALT
7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid
6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl-d(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-, sodium salt, (3R,5S,6E)- (1:1)
[3H]-Rosuvastatin
Rosuvastatin
Sodium (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[(H)methyl(methylsulfonyl)amino]-5-pyrimidinyl}-3,5-dihydroxy-6-heptenoate
(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-MethylMethanesulfonaMido)-6-(propan-2-yl)pyriMidin-5-yl]-3,5-dihydroxyhept-6-enoic acid
MFCD08460959
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here

Get all suppliers and price by the below link:

Rosuvastatin suppliers

Price: ￥297/250mg

Reference only. check more Rosuvastatin price

Related Compounds: More...
ROSUVASTATIN
854898-48-9
Rosuvastatin
1348948-55-9
rosuvastatin
1242184-42-4
Rosuvastatin D3
1133429-16-9
Rosuvastatin zinc
953412-08-3
ROSUVASTATIN Inter
615556-98-4
Rosuvastatin Sodium
147098-18-8
RosuvastatinLactone
503610-43-3
Rosuvastatin Lactone
615263-62-2
Tert-butyl 2-(2-hydroxy-2-methylpropyl)morpholine-4-carboxylate
2228110-43-6
3-(2,4-dimethyl-1H-pyrrol-3-yl)-2,2-dimethylpropan-1-ol
2228822-91-9
2-(3,4-Dihydroxy-5-methoxyphenyl)-3-methylbutanoic acid
2229561-26-4
3-(6-Chloropyridin-3-yl)-1,1-difluoro-2-methylpropan-2-amine
2228325-74-2
2-[1-(4,4-Difluorocyclohexyl)cyclobutyl]acetic acid
2229263-28-7
4-{6,6-Dimethylbicyclo[3.1.1]heptan-2-yl}-2-methylbutan-2-amine
2228692-34-8
3-{6,6-Dimethylbicyclo[3.1.1]heptan-2-yl}-2,2-dimethylpropanoic acid
2229437-73-2
4-(1H-1,2,3,4-tetrazol-5-yl)but-3-en-2-one
2229644-61-3
rac-[(1R,2R)-2-(1H-1,2,3,4-tetrazol-5-yl)cyclopropyl]methanamine
2227865-45-2
methyl 2-amino-2-[1-(1H-1,2,3,4-tetrazol-5-yl)cyclopropyl]acetate
2228112-01-2
Chemsrc provides Rosuvastatin(CAS#:287714-41-4) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of Rosuvastatin are included as well.>> amp version: Rosuvastatin

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved